{"id":888308,"date":"2025-09-22T12:01:10","date_gmt":"2025-09-22T16:01:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/"},"modified":"2025-09-22T12:01:10","modified_gmt":"2025-09-22T16:01:10","slug":"tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/","title":{"rendered":"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference"},"content":{"rendered":"

<\/p>\n

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference<\/b><\/p>\n

FREMONT, Calif.–(BUSINESS WIRE<\/a>)–Tivic Health\u00ae Systems, Inc.<\/a> (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that the company\u2019s CEO will present during the Emerging Growth virtual conference set to take place on September 24 & 25, 2025.<\/p>\n\n\n\n\n
\n

WHO:<\/b><\/p>\n<\/td>\n

\n\n\n\n\n

\nJennifer Ernst, Chief Executive Officer<\/p>\n<\/td>\n<\/tr>\n

\n

WHERE:<\/b><\/p>\n<\/td>\n

\n\n\n\n\n

\nSeptember 25, 2025<\/p>\n<\/td>\n<\/tr>\n

\n

WHEN:<\/b><\/p>\n<\/td>\n

\n\n\n\n\n

\n11:25AM – 11:55AM Eastern Time<\/p>\n<\/td>\n<\/tr>\n<\/table>\n

\nJennifer Ernst, CEO of Tivic, will deliver a formal presentation detailing the company\u2019s strategic transformation into the biopharmaceutical sector. This evolution positions Tivic as a unique innovator addressing disease by integrating both the body\u2019s biochemical and bioelectronic systems.<\/p>\n

\nIn February 2025, Tivic secured licensing rights to Statera Biopharma\u2019s TLR5 agonist portfolio, providing the company with a late-stage, highly de-risked drug candidate with a Phase III indication and multiple additional opportunities. At the center of this portfolio is Entolimod<\/b>, Tivic\u2019s lead commercial opportunity, originally developed as a military countermeasure for exposure to lethal levels of ionizing radiation. Ernst will outline the milestones achieved to date and the significance of these developments as the company advances toward commercialization of Entolimod for the treatment of Acute Radiation Syndrome (ARS).<\/b><\/p>\n

\nErnst will also address Tivic\u2019s second licensed indication, Neutropenia<\/b>\u2014a condition characterized by low white blood cell counts that compromise the body\u2019s ability to fight infection. Affecting a broad demographic due to causes ranging from genetics to cancer treatments to aging, Neutropenia represents a significant unmet medical need and a substantial market opportunity.<\/p>\n

\nAttendees are encouraged to submit questions in advance for the CEO to address during the presentation. Questions may be emailed to Questions@EmergingGrowth.com<\/b><\/a>. While time is limited, the CEO will make every effort to respond to as many inquiries as possible.<\/p>\n

\nAttendees are welcome to attend and listen to the presentation. Please register for the event at the below link.<\/p>\n

https:\/\/goto.webcasts.com\/starthere.jsp?ei=1717091&tp_key=c78a55764a&sti=tivc<\/a><\/p>\n

\nIf attendees cannot join the event live on the day of the conference, an archived webcast will also be made available on www.EmergingGrowth.com<\/a>.<\/p>\n

About the Emerging Growth<\/b><\/p>\n

\nThe Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner.<\/p>\n

\nThe Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.<\/p>\n

\nAll sessions will be conducted through video webcasts and will take place in the Eastern time zone.<\/p>\n

About Entolimod<\/b><\/p>\n

\nEntolimod is a novel Toll-like Receptor 5 (TLR5) agonist that triggers NF-kB signaling, activating antiapoptotic and cell protective mechanisms. Under the FDA\u2019s Animal Rule, Entolimod has been the subject of extensive trials for the treatment of acute radiation syndrome (ARS), and has demonstrated robust survival, enhanced GI tract recovery and improved hematopoiesis in animal models. Entolimod has been granted Fast Track Designation for ARS.<\/p>\n

\nTivic also holds the exclusive rights for Entolimod for the treatment of neutropenia, and has the option to license additional indications, including lymphocyte exhaustion, immunosenescence, and chronic radiation syndrome.<\/p>\n

About Tivic Health Systems, Inc.<\/b><\/p>\n

\nTivic\u2019s dual platform utilizes the body\u2019s biopharmaceutical and bioelectronic systems to treat unmet medical needs through targeting the immune system.<\/p>\n

Tivic\u2019s biologics compounds<\/b> activate an innate immune pathway to prevent cell death in the bone marrow and epithelial tissues across systems impacted by radiation and age. The company\u2019s lead drug candidate, Entolimod\u2122 for acute radiation syndrome, is a novel TLR5 agonist that has been granted Fast Track and Orphan Drug designations and is in late-stage development.<\/p>\n

Tivic\u2019s bioelectronic program<\/b> is developing a novel, non-invasive medical device designed to target the neural pathways implicated in many prevalent and debilitating diseases. Early trials show promising signals that Tivic\u2019s approach may regulate specific biologic responses, and the company believes its early-stage vagus nerve stimulation device has the potential to deliver clinical outcomes similar to or better than those of surgically implanted devices. To learn more about Tivic, visit: https:\/\/ir.tivichealth.com<\/a>.<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

\nThis press release may contain \u201cforward-looking statements\u201d that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cseek,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201ctarget,\u201d \u201caim,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cwould,\u201d or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems Inc.\u2019s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate, including as a result of interactions with and guidance from the FDA and other regulatory authorities; changes to the company\u2019s relationship with the its partners; timing and success of clinical trials and study results; the failure to obtain FDA or similar clearances or approvals and noncompliance with FDA or similar regulations; the company\u2019s future development of its ncVNS treatment, Entolimod and Entolasta; changes to the company\u2019s business strategy; regulatory requirements and pathways for approval; the company\u2019s ability to successfully commercialize its product candidates in the future; the potential opportunities that may be available to the company and its product candidates in the future; the company\u2019s need for, and ability to secure when needed, additional working capital; the company\u2019s ability to maintain its Nasdaq listing; and changes in tariffs, inflation, legal, regulatory, political and economic risks. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. Accordingly, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of risks and uncertainties relevant to the company, and other important factors, see Tivic Health\u2019s filings with the SEC, including, its Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on March 21, 2025, under the heading \u201cRisk Factors,\u201d as well as the company\u2019s subsequent filings with the SEC. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20250922947023\/en\/<\/a><\/span><\/p>\n

Investor Contact:
\n<\/b>
Hanover International, Inc.
\n
ir@tivichealth.com<\/a><\/p>\n

Media Contact:
\n<\/b>
Deanne Eagle or Laura Min Jackson
\n
media@tivichealth.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America California<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference FREMONT, Calif.–(BUSINESS WIRE)–Tivic Health\u00ae Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that the company\u2019s CEO will present during the Emerging Growth virtual conference set to take place on September 24 & 25, 2025. WHO: Jennifer Ernst, Chief Executive Officer WHERE: September 25, 2025 WHEN: 11:25AM – 11:55AM Eastern Time Jennifer Ernst, CEO of Tivic, will deliver a formal presentation detailing the company\u2019s strategic transformation into the biopharmaceutical sector. This evolution positions Tivic as a unique innovator addressing disease by integrating both the body\u2019s biochemical and bioelectronic systems. In February 2025, Tivic secured licensing rights to Statera Biopharma\u2019s TLR5 agonist portfolio, providing the company with … <\/p>\n

Continue reading “Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-888308","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nTivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference FREMONT, Calif.–(BUSINESS WIRE)–Tivic Health\u00ae Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that the company\u2019s CEO will present during the Emerging Growth virtual conference set to take place on September 24 & 25, 2025. WHO: Jennifer Ernst, Chief Executive Officer WHERE: September 25, 2025 WHEN: 11:25AM – 11:55AM Eastern Time Jennifer Ernst, CEO of Tivic, will deliver a formal presentation detailing the company\u2019s strategic transformation into the biopharmaceutical sector. This evolution positions Tivic as a unique innovator addressing disease by integrating both the body\u2019s biochemical and bioelectronic systems. In February 2025, Tivic secured licensing rights to Statera Biopharma\u2019s TLR5 agonist portfolio, providing the company with … Continue reading "Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-22T16:01:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference\",\"datePublished\":\"2025-09-22T16:01:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/\"},\"wordCount\":1168,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/\",\"name\":\"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-09-22T16:01:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference - Market Newsdesk","og_description":"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference FREMONT, Calif.–(BUSINESS WIRE)–Tivic Health\u00ae Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that the company\u2019s CEO will present during the Emerging Growth virtual conference set to take place on September 24 & 25, 2025. WHO: Jennifer Ernst, Chief Executive Officer WHERE: September 25, 2025 WHEN: 11:25AM – 11:55AM Eastern Time Jennifer Ernst, CEO of Tivic, will deliver a formal presentation detailing the company\u2019s strategic transformation into the biopharmaceutical sector. This evolution positions Tivic as a unique innovator addressing disease by integrating both the body\u2019s biochemical and bioelectronic systems. In February 2025, Tivic secured licensing rights to Statera Biopharma\u2019s TLR5 agonist portfolio, providing the company with … Continue reading \"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-09-22T16:01:10+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference","datePublished":"2025-09-22T16:01:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/"},"wordCount":1168,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/","name":"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-09-22T16:01:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20250922947023r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tivic-health-ceo-jennifer-ernst-to-present-at-emerging-growths-september-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tivic Health CEO Jennifer Ernst to Present at Emerging Growth\u2019s September Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888308","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=888308"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/888308\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=888308"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=888308"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=888308"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}